Inventor · disambiguated record
Aileen L. Pangan
Also filed as: PANGAN AILEEN L
18 granted patents·8 pending applications·262 citations·filing 2018–2024
95Inventor score
Files withABBVIE INC26
Top patents by PatentIndex Score
26 records- 0198US11535625B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 27, 2022·19 cites·20 claims
- 0298US11535624B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 27, 2022·19 cites·5 claims
- 0398US11535626B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1 carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 27, 2022·18 cites·20 claims
- 0498US11524964B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 13, 2022·21 cites·10 claims
- 0598US10995095B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereofABBVIE INC·Filed 2019·Granted May 4, 2021·28 cites·9 claims
- 0698US10597400B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereofABBVIE INC·Filed 2019·Granted Mar 24, 2020·36 cites·24 claims
- 0798US10550126B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Feb 4, 2020·37 cites·9 claims
- 0897US11767326B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Sep 26, 2023·7 cites·24 claims
- 0996US11976077B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therofABBVIE INC·Filed 2023·Granted May 7, 2024·6 cites·24 claims
- 1096US11795175B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 24, 2023·8 cites·24 claims
- 1196US11780848B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 10, 2023·7 cites·18 claims
- 1296US11773106B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 3, 2023·7 cites·15 claims
- 1396US11365198B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Jun 21, 2022·25 cites·22 claims
- 1492US11993606B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted May 28, 2024·1 cites·13 claims
- 1592US11564922B2Methods of treating crohn's disease and ulcerative colitisABBVIE INC·Filed 2022·Granted Jan 31, 2023·19 cites·4 claims
- 1691US11993605B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted May 28, 2024·1 cites·24 claims
- 1789US12365689B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2024·Granted Jul 22, 2025·1 cites·30 claims
- 1889US11607411B2Methods of treating Crohn's disease and ulcerative colitisABBVIE INC·Filed 2022·Granted Mar 21, 2023·2 cites·4 claims
- 1974US2024216367A1Treating spondyloarthritic and psoriatic conditions with upadacitinibABBVIE INC·Filed 2023·Application pending·0 cites
- 2071US2023364080A1Treating spondyloarthritic and psoriatic conditions with upadacitinibABBVIE INC·Filed 2022·Application pending·0 cites
- 2166US2022281882A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2022·Application pending·0 cites
- 2266US2024122923A1Methods of treating hidradenitis suppurativaABBVIE INC·Filed 2023·Application pending·0 cites
- 2362US2021228575A1Treating spondyloarthritic and psoriatic conditions with upadacitinibABBVIE INC·Filed 2020·Application pending·0 cites
- 2461US2024398790A1Treating spondyloarthritic conditions with upadacitinibABBVIE INC·Filed 2022·Application pending·0 cites
- 2561US2021361647A1Methods of treating crohn's disease and ulcerative colitisABBVIE INC·Filed 2020·Application pending·0 cites
- 2657US2019046527A1Methods of treating crohn's disease and ulcerative colitisABBVIE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aileen L. Pangan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →